NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 284 filers reported holding NEKTAR THERAPEUTICS in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,333 | +3005.4% | 1,333,668 | +2899.0% | 0.00% | – |
| Q2 2023 | $25,579 | -44.4% | 44,470 | +206.4% | 0.00% | – |
| Q3 2022 | $46,000 | -98.7% | 14,512 | -97.8% | 0.00% | -100.0% |
| Q1 2022 | $3,605,000 | +775.0% | 668,827 | +2094.3% | 0.01% | +1000.0% |
| Q4 2021 | $412,000 | -86.8% | 30,480 | -82.4% | 0.00% | -92.3% |
| Q3 2021 | $3,116,000 | +7.5% | 173,518 | +29.2% | 0.01% | -23.5% |
| Q4 2019 | $2,898,000 | -49.7% | 134,277 | -17.0% | 0.02% | -54.1% |
| Q2 2019 | $5,758,000 | -1.2% | 161,829 | -6.7% | 0.04% | -5.1% |
| Q1 2019 | $5,827,000 | +77.7% | 173,431 | +73.8% | 0.04% | +62.5% |
| Q4 2018 | $3,280,000 | -71.7% | 99,794 | -51.0% | 0.02% | -54.7% |
| Q3 2018 | $11,594,000 | +177.6% | 203,501 | +417.8% | 0.05% | +211.8% |
| Q1 2018 | $4,176,000 | -69.5% | 39,300 | -82.8% | 0.02% | -59.5% |
| Q4 2017 | $13,676,000 | -28.1% | 229,000 | -71.1% | 0.04% | -44.0% |
| Q3 2017 | $19,027,000 | +90.5% | 792,782 | +55.1% | 0.08% | +82.9% |
| Q2 2017 | $9,990,000 | -2.8% | 511,013 | +16.7% | 0.04% | -14.6% |
| Q1 2017 | $10,276,000 | +1955.2% | 437,822 | +1376.9% | 0.05% | +1500.0% |
| Q4 2015 | $500,000 | +148.8% | 29,645 | +84.5% | 0.00% | +200.0% |
| Q2 2015 | $201,000 | – | 16,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |